Home 2014


von Willebrand disease 101

Learn the basics about the most common inherited bleeding disorder.

FDA approves first implantable wireless device with remote monitoring to measure PAP in certain...

On May 28, the U.S. Food and Drug Administration (FDA) approved the CardioMEMS HF System, which measures the pulmonary artery pressures (PAP) and heart...

Study: Pradaxa reduces stroke and death, but increases GI bleeding compared to warfarin

According to a study from the U.S. Food and Drug Administration (FDA), Pradaxa (dabigatran), in comparison to warfarin, was associated with a lower risk...

Study: New drug effective for ACE-inhibitor angioedema

A Phase II study found that patients with ACE inhibitor-induced angioedema who received ecallantide were more likely to be discharged sooner than those treated...

Exercise is key part of stroke recovery

Exercise should be prescribed for stroke survivors because it can significantly reduce disability and the risk of recurrent stroke, according to “Physical Activity and...

Providing optimal care for patients with central catheters

Confused about central catheters? Here’s what you need to know.

Continuous renal replacement therapy: Dialysis for critically ill patients

This technique slowly removes wastes and excess plasma water, helping patients recover from their illness.

WHO releases new hepatitis C guidelines

The World Health Organization (WHO) has released “Guidelines for the screening, care and treatment of persons with hepatitis C infection.” Access the guidelines.

Celiac disease linked to increased risk for CAD

People with celiac disease may have a nearly twofold increased risk of coronary artery disease compared with the general population, according to research to...

Caring for patients with metabolic syndrome

A precursor to serious complications, this dangerous condition is on the rise among Americans.

Shhhhhh! Quiet zone

Nurses play a significant role in helping patients to get the sleep they need.

Benefits of exercise training in heart failure

Exercise training reduces the risk for subsequent all-cause mortality or all-cause hospitalization in women by 26%, compared with 10% in men, according to a...

FDA approves Impavido to treat leishmaniasis

On March 19, the U.S. Food and Drug Administration (FDA) approved Impavido (miltefosine) to treat a tropical disease called leishmaniasis. Read more.